COMMITMENTS AND CONTINGENCIES (Details Narrative)	Aug. 20, 2021 USD ($) shares	Jul. 30, 2021 USD ($) $ / shares shares	Jul. 27, 2021 USD ($) N $ / shares	Jun. 30, 2023 USD ($)
Subsidiary, Sale of Stock [Line Items]
Number of demands eligible security holder can make | N			3
Underwriting fees deferred		$ 6,314,525
Underwriting discount fee | $ / shares		$ 0.20
Underwriting discount		$ 3,608,300
Deferred underwriting commissions per unit | $ / shares			$ 0.35
Deferred underwriting fee payable			$ 6,314,525	$ 6,314,525
Accumulated deficit				6,014,585
Gain on underwriting commissions				299,940
Offering costs		15,401,418		$ 14,638,901
Other offering costs		764,193
Excess fair value of the founder shares sold		4,714,400
Purchase price		$ 4,150
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Option for underwriters to purchase additional units, term		45 days
Additional Units that can be purchased to cover over-allotments | shares		2,625,000
Underwriting fees deferred		$ 6,314,525
Offering costs		15,401,418
Other offering costs		$ 764,193
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Option for underwriters to purchase additional units, term		45 days
Additional Units that can be purchased to cover over-allotments | shares	2,625,000	2,625,000
Units issued during period, shares, new issues | shares	541,500
Proceeds from initial public offering, net of underwriting fees	$ 5,415,000
Underwriting fees deferred	$ 189,525